ubiquinone and Sarcoma-180

ubiquinone has been researched along with Sarcoma-180* in 3 studies

Other Studies

3 other study(ies) available for ubiquinone and Sarcoma-180

ArticleYear
Potential bioreductive alkylating agents. 4. Inhibition of coenzyme Q enzyme systems by lipoidal benzoquinone and naphthoquinone derivatives.
    Journal of medicinal chemistry, 1974, Volume: 17, Issue:7

    Topics: Alkylating Agents; Animals; Cattle; Electron Transport; In Vitro Techniques; Lipid Metabolism; Mice; Mice, Inbred Strains; Mitochondria, Muscle; Myocardium; NADH, NADPH Oxidoreductases; Naphthoquinones; Palmitic Acids; Quinones; Sarcoma 180; Structure-Activity Relationship; Succinate Dehydrogenase; Ubiquinone

1974
Quinones as anticancer agents: potential bioreductive alkylating agents.
    Cancer chemotherapy reports. Part 2, 1974, Volume: 4, Issue:4

    Topics: Adenocarcinoma; Alkylating Agents; Animals; Cattle; DNA, Neoplasm; In Vitro Techniques; Mitochondria, Muscle; Mitomycins; Myocardium; NADH, NADPH Oxidoreductases; Neoplasm Proteins; Oxidation-Reduction; Quinones; RNA, Neoplasm; Sarcoma 180; Ubiquinone

1974
The potential of coenzyme Q 10 (NSC-140865) in cancer treatment.
    Cancer chemotherapy reports. Part 2, 1974, Volume: 4, Issue:4

    Topics: Animals; Antibody Formation; Antineoplastic Agents; Chick Embryo; Cricetinae; Haplorhini; Humans; Lipid Metabolism; Metabolism, Inborn Errors; Mice; Neoplasms; Peroxides; Phenylalanine; Rabbits; Rats; Sarcoma 180; Succinate Dehydrogenase; Turkeys; Tyrosine; Ubiquinone

1974